These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 2151407

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Platelet inhibitory drugs: an in vivo method of evaluation in patients.
    Norcott HC, Goldman M, Hawker RJ, Rafiqi EI, Drolc Z, McCollum CN.
    Thromb Haemost; 1982 Dec 27; 48(3):307-10. PubMed ID: 6761890
    [Abstract] [Full Text] [Related]

  • 5. The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs.
    Kester RC.
    Ann R Coll Surg Engl; 1984 Jul 27; 66(4):241-6. PubMed ID: 6234841
    [Abstract] [Full Text] [Related]

  • 6. Effect of the specific thromboxane receptor blocking drug AH23848 in patients with angina pectoris.
    De Bono DP, Lumley P, Been M, Keery R, Ince SE, Woodings DF.
    Br Heart J; 1986 Dec 27; 56(6):509-17. PubMed ID: 2948534
    [Abstract] [Full Text] [Related]

  • 7. Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man.
    Goldman MD, Simpson D, Hawker RJ, Norcott HC, McCollum CN.
    Ann Surg; 1983 Dec 27; 198(6):713-6. PubMed ID: 6227296
    [Abstract] [Full Text] [Related]

  • 8. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
    Hornby EJ, Foster MR, McCabe PJ, Stratton LE.
    Thromb Haemost; 1989 Jun 30; 61(3):429-36. PubMed ID: 2529661
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
    Vilahur G, Casaní L, Badimon L.
    Thromb Haemost; 2007 Sep 30; 98(3):662-9. PubMed ID: 17849057
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F, Colombo M, Pierucci L, Volpi D, Dho L, Ukmar G, Rosa B, Salvati P.
    Drugs Exp Clin Res; 1993 Sep 30; 19(6):249-60. PubMed ID: 8013268
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
    Jagroop IA, Matsagas MI, Geroulakos G, Mikhailidis DP.
    Platelets; 2004 Mar 30; 15(2):117-25. PubMed ID: 15154604
    [Abstract] [Full Text] [Related]

  • 18. Effect of a selective thromboxane synthase inhibitor on arterial graft patency and platelet deposition in dogs.
    McDaniel MD, Huntsman WT, Miett TO, Cronenwett JL.
    Arch Surg; 1987 Aug 30; 122(8):887-92. PubMed ID: 2957981
    [Abstract] [Full Text] [Related]

  • 19. Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole.
    Oblath RW, Buckley FO, Green RM, Schwartz SI, DeWeese JA.
    Surgery; 1978 Jul 30; 84(1):37-44. PubMed ID: 149385
    [No Abstract] [Full Text] [Related]

  • 20. Effects of aspirin and dipyridamole on platelet function, hematology, and blood chemistry of saturation divers.
    Philp RB, Bennett PB, Andersen JC, Fields GN, McIntyre BA, Francey I, Briner W.
    Undersea Biomed Res; 1979 Jun 30; 6(2):127-46. PubMed ID: 531993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.